0001622229424B5EX-FILING FEES 0001622229 2025-05-06 2025-05-06 0001622229 1 2025-05-06 2025-05-06 iso4217:USD
Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Cogent Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                         
    
Security
Type
 
Security
Class
Title
 
Fee
Calculation
or Carry
Forward
Rule
 
Amount 
Registered 
 
Proposed 
Maximum 
Offering 
Price Per 
Unit 
 
Maximum
Aggregate
Offering
Price
 
Fee 
Rate 
 
Amount of 
Registration 
Fee 
 
Carry 
Forward 
Form 
Type 
 
Carry
Forward
File
Number
 
Carry
Forward
Initial
effective
date
 
Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities
                         
                           
 
Carry Forward Securities
                         
Carry
Forward
Securities
  Equity   Common stock, $0.001 par value per share   415(a)(6)       $50,000.00
(2)
     
S-3
 
333-264773
  5/24/2022   $4,635.00
                   
    Total Offering Amounts      $50,000.00              
                   
    Total Fees Previously Paid                   
                   
    Total Fee Offsets                   
                   
    Net Fee Due                               
 
(1)
Pursuant to Rule 415(a)(6) under the Securities Act, securities with a maximum aggregate price of $50,000.00 registered hereunder are unsold securities (the “Unsold Securities”) previously covered by the registrant’s registration statement on Form
S-3
(File
No. 333-264773)
which was initially filed with the Securities and Exchange Commission on May 6, 2022 and became effective on May 24, 2022 (the “Prior Registration Statement”), and are hereby included in the registrant’s Registration Statement on Form
S-3ASR
(File
No. 333-269707),
which was filed and became effective on February 10, 2023 (the “Registration Statement”). The registrant paid a filing fee of $4,635.00 (calculated at the filing fee rate in effect at the time of the filing of the Prior Registration Statement) relating to the Unsold Securities under the Prior Registration Statement. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this prospectus supplement to the Registration Statement.